|
End-of-day quote
Taiwan S.E.
2026-09-04
|
5-day change | 1st Jan Change | ||
| 1,310.00 TWD | -2.96% |
|
-15.21% | +209.18% |
| 08-31 | PharmaEssentia Gets US FDA's Approval for Essential Thrombocythemia Treament Drug; Shares Sink 10% | MT |
| 08-28 | US FDA approves Takeda, Protagonist's drug for rare blood cancer | RE |
Chart: Technical Analysis
Taiwan S.E.TWD
| Markets | Quality | ||
|---|---|---|---|
Taiwan S.E.
| 6446 | End-of-day quote | |
LUXEMBOURG S.E.
| 261280523 | End-of-day quote | |
LUXEMBOURG S.E.
| 261280558 | End-of-day quote |
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Bullish | Bullish | Bullish |
| Resistance | 1,585 | 1,585 | 1,545 |
| Spread/Res. | -17.35% | -17.35% | -15.21% |
| Spread/Supp. | +5.65% | +27.80% | +79.40% |
| Support | 1,240 | 1,025 | 730.2 |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Stocks
- 6446 Stock
- Charts PharmaEssentia Corporation
Select your edition
All financial news and data tailored to specific country editions
